Consequences Escalate If Firms Ignore GMP Compliance Issues
This article was originally published in The Tan Sheet
Executive Summary
A warning letter is a firm’s last “real chance” to correct GMP violations without winding up in court, but not the only chance, says FDA attorney Annamarie Kempic. She outlines factors the agency weighs when considering enforcement actions.